186 related articles for article (PubMed ID: 23403321)
1. TP53 mutations are frequent in adult acute lymphoblastic leukemia cases negative for recurrent fusion genes and correlate with poor response to induction therapy.
Chiaretti S; Brugnoletti F; Tavolaro S; Bonina S; Paoloni F; Marinelli M; Patten N; Bonifacio M; Kropp MG; Sica S; Guarini A; Foà R
Haematologica; 2013 May; 98(5):e59-61. PubMed ID: 23403321
[No Abstract] [Full Text] [Related]
2. TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens.
Kanagal-Shamanna R; Jain P; Takahashi K; Short NJ; Tang G; Issa GC; Ravandi F; Garcia-Manero G; Yin CC; Luthra R; Patel KP; Khoury JD; Montalban-Bravo G; Sasaki K; Kadia TM; Borthakur G; Konopleva M; Jain N; Garris R; Pierce S; Wierda W; Estrov Z; Cortes J; O'Brien S; Kantarjian HM; Jabbour E
Cancer; 2017 Oct; 123(19):3717-3724. PubMed ID: 28608976
[TBL] [Abstract][Full Text] [Related]
3. TP53 in adult acute lymphoblastic leukemia.
Salmoiraghi S; Rambaldi A; Spinelli O
Leuk Lymphoma; 2018 Apr; 59(4):778-789. PubMed ID: 28679301
[TBL] [Abstract][Full Text] [Related]
4. Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival.
Salmoiraghi S; Montalvo ML; Ubiali G; Tosi M; Peruta B; Zanghi P; Oldani E; Boschini C; Kohlmann A; Bungaro S; Intermesoli T; Terruzzi E; Angelucci E; Cavattoni I; Ciceri F; Bassan R; Rambaldi A; Spinelli O
Haematologica; 2016 Jun; 101(6):e245-8. PubMed ID: 26992948
[No Abstract] [Full Text] [Related]
5. Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia.
Demir S; Boldrin E; Sun Q; Hampp S; Tausch E; Eckert C; Ebinger M; Handgretinger R; Kronnie GT; Wiesmüller L; Stilgenbauer S; Selivanova G; Debatin KM; Meyer LH
Haematologica; 2020 Jan; 105(1):170-181. PubMed ID: 31073076
[TBL] [Abstract][Full Text] [Related]
6. High prevalence and inferior long-term outcomes for TP53 mutations in therapy-related acute lymphoblastic leukemia.
Pourhassan H; Yang D; Afkhami M; Pillai R; Ball B; Al Malki M; Salhotra A; Ali H; Artz A; Curtin P; Armenian S; Stein A; Forman SJ; Marcucci G; Pullarkat V; Nakamura R; Aldoss I
Am J Hematol; 2022 May; 97(5):E171-E173. PubMed ID: 35132678
[No Abstract] [Full Text] [Related]
7. MYC Expression Is Associated With p53 Expression and TP53 Aberration and Predicts Poor Overall Survival in Acute Lymphoblastic Leukemia/Lymphoma.
Gao L; Harbaugh B; Parr K; Patel P; Golem S; Zhang D; Woodroof J; Cui W
Am J Clin Pathol; 2022 Jan; 157(1):119-129. PubMed ID: 34528662
[TBL] [Abstract][Full Text] [Related]
8. Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.
Hof J; Krentz S; van Schewick C; Körner G; Shalapour S; Rhein P; Karawajew L; Ludwig WD; Seeger K; Henze G; von Stackelberg A; Hagemeier C; Eckert C; Kirschner-Schwabe R
J Clin Oncol; 2011 Aug; 29(23):3185-93. PubMed ID: 21747090
[TBL] [Abstract][Full Text] [Related]
9. Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia.
Chitadze G; Stengel A; John-Klaua C; Bruckmüller J; Trautmann H; Kotrova M; Darzentas F; Kelm M; Pal K; Darzentas N; Bastian L; Kehden B; Wessels W; Ströh AS; Oberg HH; Altrock PM; Baer C; Meggendorfer M; Gökbuget N; Baldus CD; Haferlach C; Brüggemann M
Blood; 2023 Mar; 141(13):1640-1644. PubMed ID: 36450137
[No Abstract] [Full Text] [Related]
10. Mutational analysis of TP53 gene in Tunisian familial hematological malignancies and sporadic acute leukemia cases.
Hamadou WS; Besbes S; Bourdon V; Youssef YB; Laatiri MA; Noguchi T; Khélif A; Sobol H; Soua Z
Fam Cancer; 2017 Jan; 16(1):153-157. PubMed ID: 27619989
[TBL] [Abstract][Full Text] [Related]
11. Therapy-related B-cell acute lymphoblastic leukemia in adults has unique genetic profile with frequent loss of TP53 and inferior outcome.
Barnea Slonim L; Gao J; Burkart M; Odetola OE; Kocherginsky M; Dinner SN; Lu X; Wehbe F; Jennings L; Altman JK; Mirza KM; Chen YH; Sukhanova M
Leukemia; 2021 Jul; 35(7):2097-2101. PubMed ID: 33087830
[No Abstract] [Full Text] [Related]
12. Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.
Driessen EM; van Roon EH; Spijkers-Hagelstein JA; Schneider P; de Lorenzo P; Valsecchi MG; Pieters R; Stam RW
Haematologica; 2013 Jun; 98(6):937-44. PubMed ID: 23403319
[TBL] [Abstract][Full Text] [Related]
13. Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.
Spinelli O; Peruta B; Tosi M; Guerini V; Salvi A; Zanotti MC; Oldani E; Grassi A; Intermesoli T; Micò C; Rossi G; Fabris P; Lambertenghi-Deliliers G; Angelucci E; Barbui T; Bassan R; Rambaldi A
Haematologica; 2007 May; 92(5):612-8. PubMed ID: 17488684
[TBL] [Abstract][Full Text] [Related]
14. Acute lymphoblastic leukemia with low hypodiploid/near triploid karyotype is a specific clinical entity and exhibits a very high TP53 mutation frequency of 93%.
Mühlbacher V; Zenger M; Schnittger S; Weissmann S; Kunze F; Kohlmann A; Bellos F; Kern W; Haferlach T; Haferlach C
Genes Chromosomes Cancer; 2014 Jun; 53(6):524-36. PubMed ID: 24619868
[TBL] [Abstract][Full Text] [Related]
15.
Comeaux EQ; Mullighan CG
Cold Spring Harb Perspect Med; 2017 Mar; 7(3):. PubMed ID: 28003275
[TBL] [Abstract][Full Text] [Related]
16. A specific linkage between the incidence of TP53 mutations and type of chromosomal translocations in B-precursor acute lymphoblastic leukemia cell lines.
Inukai T; Zhang X; Kameyama T; Suzuki Y; Yoshikawa K; Kuroda I; Nemoto A; Akahane K; Sato H; Goi K; Nakamoto K; Hamada J; Tada M; Moriuchi T; Sugita K
Am J Hematol; 2010 Jul; 85(7):535-7. PubMed ID: 20575032
[No Abstract] [Full Text] [Related]
17. Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis.
Saiki R; Ogawa S
Blood Cancer Discov; 2023 Mar; 4(2):102-105. PubMed ID: 36779909
[TBL] [Abstract][Full Text] [Related]
18. Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis.
Kim R; Bergugnat H; Larcher L; Duchmann M; Passet M; Gachet S; Cuccuini W; Lafage-Pochitaloff M; Pastoret C; Grardel N; Asnafi V; Schäfer BW; Delabesse E; Itzykson R; Adès L; Hicheri Y; Chalandon Y; Graux C; Chevallier P; Hunault M; Leguay T; Huguet F; Lhéritier V; Dombret H; Soulier J; Rousselot P; Boissel N; Clappier E
Blood Cancer Discov; 2023 Mar; 4(2):134-149. PubMed ID: 36630200
[TBL] [Abstract][Full Text] [Related]
19. [The effect of TP53 mutations on the clinical outcomes of Ph-negative B-acute lymphoblastic leukemia following allogeneic hematopoietic stem cell transplantation].
Cao XY; Zhang Y; Liu DY; Zhang JP; Wei ZJ; Xiong M; Sun RJ; Lu Y; Zhou JR; Zhao YL; Ma W; Zhang W
Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):908-914. PubMed ID: 33333693
[No Abstract] [Full Text] [Related]
20. TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis.
Stengel A; Schnittger S; Weissmann S; Kuznia S; Kern W; Kohlmann A; Haferlach T; Haferlach C
Blood; 2014 Jul; 124(2):251-8. PubMed ID: 24829203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
